Evidence map›Paper›PMID 33144287›Full record

ArticleCold Spring Harbor molecular case studies2020

Recurrent

Dong-Anh Khuong-Quang, Lauren M Brown, Marie Wong, Chelsea Mayoh, Alexandra Sexton-Oates, Amit Kumar, Mark Pinese, Sumanth Nagabushan, Loretta Lau, Louise E Ludlow and 10 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Future oncology (London, England) · 2025
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Dong-Anh Khuong-QuangChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.ORCID 0000-0001-6305-7790
Lauren M BrownChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.ORCID 0000-0002-4322-8203
Marie WongChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.ORCID 0000-0003-0066-6606
Chelsea MayohChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.ORCID 0000-0002-6398-3046
Alexandra Sexton-OatesMurdoch Children's Research Institute, Royal Children's Hospital, Parkville, 3052, Australia.
Amit KumarChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.
Mark PineseChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.ORCID 0000-0001-5078-6687
Sumanth NagabushanKids Cancer Centre, Sydney Children's Hospital, Randwick, 2031, Australia.
Loretta LauChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.ORCID 0000-0002-3172-0970
Louise E LudlowMurdoch Children's Research Institute, Royal Children's Hospital, Parkville, 3052, Australia.
Andrew J GiffordChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.ORCID 0000-0002-4092-2347
Michael RodriguezDepartment of Anatomical Pathology, Prince of Wales Hospital, Randwick, 2031, Australia.
Jayesh DesaiPeter MacCallum Cancer Centre, Melbourne, 3000, Australia.ORCID 0000-0003-4246-9344
Stephen B FoxSir Peter MacCallum Department of Oncology, University of Melbourne, 3000, Australia.
Michelle HaberChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.ORCID 0000-0003-2036-8817
David S ZieglerChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.
Jordan R HansfordChildren's Cancer Centre, Royal Children's Hospital, Parkville, 3052, Australia.ORCID 0000-0001-7733-383X
Glenn M MarshallChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.
Mark J CowleyChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.ORCID 0000-0002-9519-5714
Paul G EkertChildren's Cancer Institute, University of New South Wales, Randwick, 2031, Australia.ORCID 0000-0002-2976-8617
UNSW Sydney · AURoyal Children's Hospital · AUThe University of Melbourne · AUPeter MacCallum Cancer Centre · AUPrince of Wales Hospital · AUSydney Children's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of rearrangements driving expression of neurotrophic receptor tyrosine kinase (

Indexed as

Biomarkers, TumorBrain NeoplasmsCalponinsCentral Nervous System NeoplasmsChildFemaleGene Expression Regulation, NeoplasticHumansInfantMaleMembrane GlycoproteinsOncogene Proteins, FusionPhosphoproteinsProtein Kinase InhibitorsReceptor, trkAReceptor, trkBBiomarkers, TumorCalponinsMembrane GlycoproteinsNTRK1 protein, humanOncogene Proteins, FusionPhosphoproteinsProtein Kinase InhibitorsReceptor, trkAReceptor, trkBSPECC1L protein, humantropomyosin-related kinase-B, humanneoplasm of the central nervous system

Identifiers

PMID33144287
PMCPMC7784491
OpenAlexW3096400956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.